Just another example of JHL losing value. She walked away from the first deal at closing and the second deal cost her an additional $20-30 million for waiting. Now the IPO made that valuation and pie large enough that "everyone wins" with the second transaction, but make no mistake, she could have acquired the US based Lincore a couple years ago for a fraction of the cost and put together with Hills Health and spun off and pocketed all the IPO value.
So simply put, just on this company transaction, she has wasted up to $50 million in shareholder value. Think about that.
To answer your question, the first transaction was disclosed after it died, the second obviously was disclosed to the ASX.
HIL Price at posting:
38.5¢ Sentiment: Sell Disclosure: Not Held
